(-)-Epigallocatechin-3-gallate and DZNep reduce polycomb protein level via a proteasome-dependent mechanism in skin cancer cells - Wikidata - awgldk - TriplyDB

(-)-Epigallocatechin-3-gallate and DZNep reduce polycomb protein level via a proteasome-dependent mechanism in skin cancer cells

(-)-Epigallocatechin-3-gallate and DZNep reduce polycomb protein level via a proteasome-dependent mechanism in skin cancer cells

http://www.wikidata.org/entity/Q35230325

about

Where Environment Meets Cognition: A Focus on Two Developmental Intellectual Disability Disorders EZH2 in Bladder Cancer, a Promising Therapeutic Target Diverse involvement of EZH2 in cancer epigenetics Pharmacological reversal of histone methylation presensitizes pancreatic cancer cells to nucleoside drugs: in vitro optimization and novel nanoparticle delivery studies Deazaneplanocin a is a promising drug to kill multiple myeloma cells in their niche EZH2: not EZHY (easy) to deal.Tea, coffee, and caffeine and early-onset basal cell carcinoma in a case-control study.Role of EZH2 in cancer stem cells: from biological insight to a therapeutic target.Epigenetic modifications by dietary phytochemicals: implications for personalized nutrition EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumours to TopoII inhibitors.Gene regulation mediated by microRNAs in response to green tea polyphenol EGCG in mouse lung cancer.Identification of a population of epidermal squamous cell carcinoma cells with enhanced potential for tumor formation.De novo peptide design and experimental validation of histone methyltransferase inhibitors.3-Deazaneplanocin A (DZNep), an inhibitor of the histone methyltransferase EZH2, induces apoptosis and reduces cell migration in chondrosarcoma cells.The green tea catechin epigallocatechin gallate induces cell cycle arrest and shows potential synergism with cisplatin in biliary tract cancer cells.Wedelolactone disrupts the interaction of EZH2-EED complex and inhibits PRC2-dependent cancer.Survival of skin cancer stem cells requires the Ezh2 polycomb group protein.A proteasome inhibitor-stimulated Nrf1 protein-dependent compensatory increase in proteasome subunit gene expression reduces polycomb group protein level Targeting EZH2 regulates tumor growth and apoptosis through modulating mitochondria dependent cell-death pathway in HNSCC.Dietary components as epigenetic-regulating agents against cancer The Bmi-1 helix-turn and ring finger domains are required for Bmi-1 antagonism of (-) epigallocatechin-3-gallate suppression of skin cancer cell survival The Polycomb Group Protein EZH2 Impairs DNA Damage Repair Gene Expression in Human Uterine Fibroids Synthesis of PLGA nanoparticles of tea polyphenols and their strong in vivo protective effect against chemically induced DNA damage.Natural compound-derived epigenetic regulators targeting epigenetic readers, writers and erasers.The polycomb group protein EZH2 is a novel therapeutic target in tongue cancer.EZH2-mediated Puma gene repression regulates non-small cell lung cancer cell proliferation and cisplatin-induced apoptosis.S-adenosyl methionine specifically protects the anticancer effect of 5-FU via DNMTs expression in human A549 lung cancer cells.New Enlightenment of Skin Cancer Chemoprevention through Phytochemicals: In Vitro and In Vivo Studies and the Underlying Mechanisms Epigenetic regulation of miRNA-cancer stem cells nexus by nutraceuticals.EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis.Tipping the lysine methylation balance in disease Synthesis and pharmacology of proteasome inhibitors.Epigenetic effects of natural polyphenols: a focus on SIRT1-mediated mechanisms.Epigenetic cancer prevention mechanisms in skin cancer.Roles of enhancer of zeste homolog 2: from skeletal muscle differentiation to rhabdomyosarcoma carcinogenesis.Immunity: plants as effective mediators.The role of polycomb repressive complexes in biliary tract cancer.Synergistic enhancement of anticancer effects on numerous human cancer cell lines treated with the combination of EGCG, other green tea catechins, and anticancer compounds.Impact of Epigenetic Dietary Components on Cancer through Histone Modifications.Dietary phytochemicals as epigenetic modifiers in cancer: Promise and challenges.

P2860

Q26740071-B29307F9-CD9A-4861-8B3B-B14C8E7EB8BA Q28082054-2A7C34B9-4962-43F7-BE9E-42656186A325 Q28084911-1ADB6751-CE88-4BCF-82C6-EC0A85F047C5 Q28535154-33238C68-7EDD-4509-8B3B-D1B6443D28FA Q28543228-0A23C966-A250-4D2E-8CC1-0D1EC4FBF627 Q33610902-D417E184-A603-4439-89C6-387BDDD111A9 Q33762312-58C6B31E-8822-4987-97EB-BDD5057ABAD9 Q33914216-1C4D3EE8-13B0-4B98-93F0-52AFBBDD4E3C Q34129835-7E2D50A3-C48D-47B3-A893-85CC01807D9C Q34460151-7C642426-8ED5-4EDB-931D-9D7BFDBA4CFE Q35005173-5F795911-F2A1-4EC3-A680-183058FDAE97 Q35078367-75AE33C2-AE72-4F3B-BE62-8C8E61591EF8 Q35108673-CC0A1C58-967E-4BEB-9774-1EA08257DCBE Q35172602-487D6CB0-24DC-4842-95A0-1E502A36F65C Q35671261-E6BB996A-C09D-4472-9E22-4E2F50F99CBF Q35955196-B87F1F9A-CCF8-49FF-A179-53FF954E7D91 Q36087138-F956F85C-B854-4C9E-8468-611181CF36CC Q36332850-1AC3ABD1-2AF5-4364-90DD-16D991F7DF9F Q36545265-83C4673D-0FB3-4BE0-8C64-2B8ECF9E86CB Q36576975-7863556F-568A-44C7-9DAC-4B9CFDCDBC53 Q36588471-8F59AA1D-8CED-4312-9382-205980AEF524 Q36791100-E0C81B1D-3470-4DCB-A6CB-876650C7B9DD Q36873535-089DEB14-83ED-4CE0-BD38-F05DFC34E771 Q37114055-60954AFD-DA7C-4406-BF37-A07E0AF88B5F Q37589165-09466FED-7375-4AAB-B3AE-D16DF3F645B3 Q37636628-50166A5A-364D-4932-B981-28B20FE05C6C Q37641100-2ABEFEAA-F2BD-4131-AA0B-9AB44FBC49D6 Q37686669-38CA540A-6B13-4254-B012-EBED62941100 Q37719054-32C7C025-1306-4480-9939-FD1656DF2196 Q38019814-B11936F5-B02E-4C0A-9121-4A017B69606C Q38061868-AD3DE566-FC2C-41C8-AA0D-3D833E4A6015 Q38092777-F47F8911-479D-45D6-AC10-8AE10F7EC353 Q38123766-CB02207E-0BA3-4A11-A531-DDC398A25305 Q38125641-498D6863-188F-4033-A4DF-6A9A4C05A251 Q38185265-99542024-6303-4B4D-A918-97C7E1D79B78 Q38190597-4F0D9058-6D3D-4C89-9199-009869EE8B32 Q38271374-9155D4F9-451B-45A1-BBC2-7C87A9CE5061 Q38302024-BD2948E6-D285-45BF-892F-BC615DAFB624 Q38428453-CD98C824-981D-4FA6-854D-518B5F85A76E Q38818485-2EE59B70-6265-46AC-9621-1D736CC8058F

P2860

(-)-Epigallocatechin-3-gallate and DZNep reduce polycomb protein level via a proteasome-dependent mechanism in skin cancer cells

http://www.wikidata.org/entity/Q35230325

description

2011 nî lūn-bûn

@nan

2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

(-)-Epigallocatechin-3-gallate ...... mechanism in skin cancer cells

@ast

(-)-Epigallocatechin-3-gallate ...... mechanism in skin cancer cells

@en

type

label

(-)-Epigallocatechin-3-gallate ...... mechanism in skin cancer cells

@ast

(-)-Epigallocatechin-3-gallate ...... mechanism in skin cancer cells

@en

prefLabel

(-)-Epigallocatechin-3-gallate ...... mechanism in skin cancer cells

@ast

(-)-Epigallocatechin-3-gallate ...... mechanism in skin cancer cells

@en

P1433

Q35230325-F8284C7F-12EB-4393-BB3E-2BB654BB7A7C

P1476

Q35230325-C8DFD472-9B92-40A0-8A09-117814A735CB

P2093

Q35230325-125629CC-595A-435D-BCAD-1F02A285A321

Q35230325-2631C7AD-6745-4C50-8001-292E66B6A2EA

Q35230325-644B43D8-58E9-411A-8854-696AF026E54D

Q35230325-66A485FA-827D-4DA6-9F90-F9E060289A36

Q35230325-68498F64-59FE-4B2D-8D57-E439F075F541

Q35230325-EB6D366B-4BE3-4B7B-A3BE-9A511C3F526D

P2860

Q35230325-032DC067-1E93-40FF-960C-DE2FD73585A6

Q35230325-0745F39C-D996-4EC6-9FCB-A96FE1CBC081

Q35230325-08AE90D5-250C-48B0-A4C9-520A93FE56E9

Q35230325-107BB466-9A42-4DC0-8B37-0A9D44B05F2E

Q35230325-130D0C4C-BCB0-4820-A798-799E1799E143

Q35230325-140AF98B-43C0-46C8-8FC3-7801FC771384

Q35230325-1E0152F2-26B5-4FA4-8030-0EC8E3CE9DDC

Q35230325-2731C86D-6070-48F6-BB75-0CBE22175207

Q35230325-30AA072C-EDEE-444C-B54D-BCCC7F22E225

Q35230325-322F5AFE-173F-40C6-8A7A-C6797460B476

P304

Q35230325-BDEC5F3B-FD62-4294-AB02-E77D4C109FFF

P31

Q35230325-DF14F5AD-4933-408B-B1DA-883AF184B0E4

P356

Q35230325-1F788308-A1F9-4FA0-8323-BB69C4A93680

P407

Q35230325-4BBEDC22-5CDE-453E-95EC-1E018D60A482

P433

Q35230325-84C2A5EA-4E8C-4B75-9110-4D53064CD108

P478

Q35230325-F38AFA46-010E-4F56-B812-53F9E5425A7A

P577

Q35230325-B813CDE1-234B-4F04-9EE2-9F2F9E59FF59

P5875

Q35230325-6044F82F-BA7F-4A9C-A586-C12898FC0491

P698

Q35230325-5FFA876B-DE17-49CC-9973-8FBAE8B93F84

P932

Q35230325-B94C3D72-9D86-4049-83FE-CB37AD04BCA4

P356

P1433

P1476

(-)-Epigallocatechin-3-gallate ...... mechanism in skin cancer cells

@en

P2093

Bingshe Han

http://www.w3.org/2001/XMLSchema#string

Richard L Eckert

http://www.w3.org/2001/XMLSchema#string

Sivaprakasam Balasubramanian

http://www.w3.org/2001/XMLSchema#string

Subhasree Roy Choudhury

http://www.w3.org/2001/XMLSchema#string

Victor E Marquez

http://www.w3.org/2001/XMLSchema#string

Yap Ching Chew

http://www.w3.org/2001/XMLSchema#string

P2860

Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation

Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity

Structure of a Bmi-1-Ring1B polycomb group ubiquitin ligase complex

Protein kinase Cdelta regulates keratinocyte death and survival by regulating activity and subcellular localization of a p38delta-extracellular signal-regulated kinase 1/2 complex

miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis

Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein

Molecular basis for the discrimination of repressive methyl-lysine marks in histone H3 by Polycomb and HP1 chromodomains

Transcriptional repression mediated by the human polycomb-group protein EED involves histone deacetylation

Green tea polyphenol stimulates cancer preventive effects of celecoxib in human lung cancer cells by upregulation of GADD153 gene

SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex

P304

1525-1532

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CARCIN/BGR171

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2011-07-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51530284

http://www.w3.org/2001/XMLSchema#string

P698

21798853

http://www.w3.org/2001/XMLSchema#string

P932

3179425

http://www.w3.org/2001/XMLSchema#string